ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14225QMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 4 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14226RMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 4 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14247WMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 5 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14248XMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 3 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14249YMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 7 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14250BMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 5 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14255GMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 7 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14266WMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 5 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14267XMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 7 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14268YMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 7 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14269BMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 7 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14277KMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 3 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14278LMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 3 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14288BMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 7 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14289CMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 3 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14298MMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 5 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14566PMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 8 | $6909.97 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
ATEZOLIZUMAB
Source | Section 100 (CT) |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
14575DMP | ATEZOLIZUMAB atezolizumab 1.875 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 8 | $6747.37 | $31.60 | $31.60 |
Available brands | |||||||
Tecentriq SC |
- Legend
- MPMedical Practitioner